Related Experiment Videos

De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis

D J Nikolic-Paterson1, Z Jun, G H Tesch

  • 1Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia.

Insights

This study reveals that CD44 and hyaluronan interactions are crucial for mesangial cell proliferation during rat anti-Thy-1 nephritis. These findings highlight a key mechanism in kidney disease progression.

Area of Science:

  • Nephrology
  • Cell Biology
  • Immunology

Background:

  • CD44 is a cell-surface receptor for hyaluronan, mediating cell-matrix interactions vital for cellular functions like migration.
  • Mesangial proliferative response is a key feature in various kidney diseases, including anti-Thy-1 nephritis.

Purpose of the Study:

  • To investigate the expression and role of CD44 and hyaluronan in the mesangial proliferative response in rat anti-Thy-1 nephritis.
  • To elucidate the functional interaction of the CD44/hyaluronan receptor-ligand pair in this experimental nephritis model.

Main Methods:

  • Immunohistochemistry to detect CD44 and hyaluronan expression in normal and nephritic rat kidneys.
  • Double-staining with proliferating cell nuclear antigen (PCNA) to assess mesangial cell proliferation.
  • In vitro studies using rat mesangial cells to analyze CD44 expression and hyaluronan-dependent aggregation.

Main Results:

  • CD44 expression was observed in normal kidney structures and significantly increased in glomerular macrophages during nephritis.
  • De novo CD44 expression by mesangial cells correlated with their proliferation phase.
  • Hyaluronan deposition was detected in areas with proliferating CD44+ cells, indicating a functional interaction.
  • In vitro, rat mesangial cells expressed CD44, and anti-CD44 antibody inhibited hyaluronan-dependent cell aggregation.

Conclusions:

  • The CD44/hyaluronan receptor-ligand pair plays a significant role in mediating mesangial cell proliferation during rat anti-Thy-1 nephritis.
  • These findings suggest that targeting the CD44/hyaluronan pathway could be a therapeutic strategy for proliferative glomerulonephritis.

Related Concept Videos